Endothelins. Myocardial actions of a new class of cytokines

B K Krämer1, M Nishida, R A Kelly

  • 1Third Department of Medicine, University of Tübingen, FRG.

Circulation
|January 1, 1992
PubMed

Insights

Cardiac myocytes and endothelial cells interact dynamically, influencing each other's function and phenotype. This crosstalk is vital for heart remodeling, angiogenesis, and responding to cardiac injury.

Area of Science:

  • Cardiovascular Biology
  • Cellular Interactions
  • Myocardial Physiology

Background:

  • Growing evidence suggests dynamic in vivo interactions between cardiac myocytes and microvascular endothelial cells.
  • These interactions regulate cardiac myocyte and endothelial cell phenotype and function.

Purpose of the Study:

  • To explore the bidirectional communication between cardiac myocytes and endothelial cells.
  • To understand the role of this crosstalk in cardiac function, remodeling, and injury response.

Main Methods:

  • The study is based on existing evidence and theoretical frameworks.
  • It synthesizes findings on intercellular signaling pathways in the heart.

Main Results:

  • Endothelial cells release factors (e.g., endothelins) that modulate cardiac myocyte contractility.
  • Cardiac myocytes release cytokines influencing endothelial cell proliferation and angiogenesis.

Conclusions:

  • Endothelial cell-cardiac myocyte interactions are crucial for maintaining cardiac homeostasis.
  • This crosstalk plays a significant role in myocardial remodeling, angiogenesis, and cardiac injury.
  • Understanding these interactions is key to developing novel therapeutic strategies for heart disease.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...